These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28925904)

  • 1. Factors Associated with Pulmonary Embolism Recurrence and the Benefits of Long-term Anticoagulant Therapy.
    Anniccherico-Sanchez FJ; Alonso-Martinez JL; Urbieta-Echezarreta MA; Villar-Garcia I; Rojo-Alvaro J
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):205-211. PubMed ID: 28925904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
    Agnelli G; Prandoni P; Becattini C; Silingardi M; Taliani MR; Miccio M; Imberti D; Poggio R; Ageno W; Pogliani E; Porro F; Zonzin P;
    Ann Intern Med; 2003 Jul; 139(1):19-25. PubMed ID: 12834314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
    Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
    Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Cini M; Mattarozzi S
    J Thromb Haemost; 2005 May; 3(5):955-61. PubMed ID: 15869591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer testing to determine the duration of anticoagulant therapy.
    Palareti G; Cosmi B; Legnani C
    Curr Opin Pulm Med; 2007 Sep; 13(5):393-7. PubMed ID: 17940483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation after an acute pulmonary embolism].
    Le Mao R; Tromeur C; Couturaud F
    Presse Med; 2017; 46(7-8 Pt 1):728-738. PubMed ID: 28756076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.
    Grau E; Tenías JM; Soto MJ; Gutierrez MR; Lecumberri R; Pérez JL; Tiberio G;
    Crit Care Med; 2007 Aug; 35(8):1937-41. PubMed ID: 17581488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-dimer is a predictor of clot resolution in patients with pulmonary thromboembolism: A retrospective cohort study.
    An J; Sun B; Ji Y; Zhang Z; Zhai Z; Wang C
    Clin Respir J; 2020 Jun; 14(6):549-556. PubMed ID: 32052554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep vein thrombosis and pulmonary embolism.
    Di Nisio M; van Es N; Büller HR
    Lancet; 2016 Dec; 388(10063):3060-3073. PubMed ID: 27375038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
    Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
    Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
    Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
    N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.
    van Hylckama Vlieg A; Baglin CA; Luddington R; MacDonald S; Rosendaal FR; Baglin TP
    J Thromb Haemost; 2015 Sep; 13(9):1642-52. PubMed ID: 26178257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.